Arrowhead Pharmaceuticals Ownership 2024 | Who Owns Arrowhead Pharmaceuticals Now?
Institutional Ownership
79.24%
Insider Ownership
4.47%
Retail Ownership
16.29%
Institutional Holders
276.00
Arrowhead Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 12.72% | 0.01% | 15,683,206 | 336,569 | 2.19% | 407,606,524 | Jun 30, 2024 |
| VANGUARD GROUP INC | 9.91% | 0.01% | 12,214,101 | -189,949 | -1.53% | 317,444,486 | Jun 30, 2024 |
| AVORO CAPITAL ADVISORS LLC | 7.21% | 3.08% | 8,888,888 | 333,333 | 3.90% | 231,022,199 | Jun 30, 2024 |
| FMR LLC | 5.53% | 0.01% | 6,812,233 | 417,605 | 6.53% | 177,049,933 | Jun 30, 2024 |
| STATE STREET CORP | 4.74% | 0.01% | 5,837,762 | -722,941 | -11.02% | 151,723,434,000 | Jun 30, 2024 |
| SLATE PATH CAPITAL LP | 3.36% | 2.05% | 4,139,000 | - | - | 107,572,610 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 2.59% | 2.11% | 3,189,389 | 152,721 | 5.03% | 82,892,220 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.38% | 0.01% | 2,937,948 | 183,314 | 6.65% | 76,372,209 | Jun 30, 2024 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 2.08% | 0.04% | 2,560,833 | 801,950 | 45.59% | 66,557,000 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 1.88% | 0.00% | 2,315,705 | -322,358 | -12.22% | 60,185,173 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 1.86% | 0.02% | 2,290,154 | 1,356,254 | 145.22% | 59,521,102 | Jun 30, 2024 |
| MORGAN STANLEY | 1.47% | 0.00% | 1,815,278 | 679,411 | 59.81% | 47,179,075 | Jun 30, 2024 |
| NORGES BANK | 1.29% | 0.01% | 1,585,320 | 1,585,320 | 100.00% | 41,202,467 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 1.07% | 0.01% | 1,322,718 | 22,069 | 1.70% | 34,377,441,000 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.02% | 0.01% | 1,263,442 | 213,903 | 20.38% | 32,836,857 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.88% | 0.01% | 1,085,069 | 30,086 | 2.85% | 28,200,946 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 0.81% | 0.66% | 1,000,000 | 400,000 | 66.67% | 25,990,000 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.81% | 0.00% | 994,361 | 10,606 | 1.08% | 25,843,442 | Jun 30, 2024 |
| ROKOS CAPITAL MANAGEMENT LLP | 0.76% | 0.15% | 939,984 | -289,164 | -23.53% | 24,410,662 | Jun 30, 2024 |
| AQUILO CAPITAL MANAGEMENT, LLC | 0.74% | 22.76% | 908,474 | - | - | 23,611,239 | Jun 30, 2024 |
Arrowhead Pharmaceuticals's largest institutional shareholder is BLACKROCK INC., holding 12.72% of the company's total share outstanding, currently valued at $407.61M. The top 10 institutional shareholders own together 52.38% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AQUILO CAPITAL MANAGEMENT, LLC | 0.74% | 22.76% | 908,474 | - | - | 23,611,239 | Jun 30, 2024 |
| WESTERN FINANCIAL CORP/CA | 0.67% | 12.88% | 820,239 | - | - | 21,318,012 | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 0.09% | 3.64% | 111,133 | 111,133 | 100.00% | 2,888,347 | Jun 30, 2024 |
| AVORO CAPITAL ADVISORS LLC | 7.21% | 3.08% | 8,888,888 | 333,333 | 3.90% | 231,022,199 | Jun 30, 2024 |
| M28 CAPITAL MANAGEMENT LP | 0.05% | 2.27% | 67,400 | - | - | 1,751,726 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 2.59% | 2.11% | 3,189,389 | 152,721 | 5.03% | 82,892,220 | Jun 30, 2024 |
| SLATE PATH CAPITAL LP | 3.36% | 2.05% | 4,139,000 | - | - | 107,572,610 | Jun 30, 2024 |
| PRIVIUM FUND MANAGEMENT B.V. | 0.23% | 1.85% | 286,936 | 13,000 | 4.75% | 7,236,526 | Jun 30, 2024 |
| JOHNSON & JOHNSON | 0.20% | 1.61% | 247,598 | - | - | 6,435,072 | Jun 30, 2024 |
| WEALTH EFFECTS LLC | 0.13% | 1.50% | 159,600 | -4,860 | -2.96% | 4,148,006 | Jun 30, 2024 |
| HOUND PARTNERS, LLC | 0.22% | 1.41% | 269,929 | 269,929 | 100.00% | 7,015,455 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 0.81% | 0.66% | 1,000,000 | 400,000 | 66.67% | 25,990,000 | Jun 30, 2024 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 0.08% | 0.50% | 102,262 | 29,963 | 41.44% | 2,657,789 | Jun 30, 2024 |
| E. OHMAN J:OR ASSET MANAGEMENT AB | 0.58% | 0.46% | 714,206 | 74,046 | 11.57% | 18,562,214 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 0.03% | 0.28% | 35,000 | - | - | 909,650 | Jun 30, 2024 |
| MYECFO, LLC | 0.01% | 0.28% | 18,497 | - | - | 480,737 | Jun 30, 2024 |
| MOODY ALDRICH PARTNERS LLC | 0.04% | 0.25% | 49,879 | -3,160 | -5.96% | 1,296,355 | Jun 30, 2024 |
| EFG ASSET MANAGEMENT (NORTH AMERICA) CORP. | 0.04% | 0.23% | 51,828 | 24,083 | 86.80% | 1,345,714 | Jun 30, 2024 |
| FOX RUN MANAGEMENT, L.L.C. | 0.04% | 0.22% | 44,989 | 16,891 | 60.11% | 1,169,264 | Jun 30, 2024 |
| EVENTIDE ASSET MANAGEMENT, LLC | 0.38% | 0.21% | 463,894 | 150,605 | 48.07% | 12,056,605 | Jun 30, 2024 |
The largest Arrowhead Pharmaceuticals shareholder by % of total assets is AQUILO CAPITAL MANAGEMENT, LLC. The company owns 908.47K shares of Arrowhead Pharmaceuticals (ARWR), representing 22.76% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NORGES BANK | 1.29% | 0.01% | 1,585,320 | 1,585,320 | 100.00% | 41,202,467 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 1.86% | 0.02% | 2,290,154 | 1,356,254 | 145.22% | 59,521,102 | Jun 30, 2024 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 2.08% | 0.04% | 2,560,833 | 801,950 | 45.59% | 66,557,000 | Jun 30, 2024 |
| MORGAN STANLEY | 1.47% | 0.00% | 1,815,278 | 679,411 | 59.81% | 47,179,075 | Jun 30, 2024 |
| FMR LLC | 5.53% | 0.01% | 6,812,233 | 417,605 | 6.53% | 177,049,933 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 0.81% | 0.66% | 1,000,000 | 400,000 | 66.67% | 25,990,000 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.31% | 0.02% | 383,826 | 383,826 | 100.00% | 9,975,638 | Jun 30, 2024 |
| BLACKROCK INC. | 12.72% | 0.01% | 15,683,206 | 336,569 | 2.19% | 407,606,524 | Jun 30, 2024 |
| AVORO CAPITAL ADVISORS LLC | 7.21% | 3.08% | 8,888,888 | 333,333 | 3.90% | 231,022,199 | Jun 30, 2024 |
| HOUND PARTNERS, LLC | 0.22% | 1.41% | 269,929 | 269,929 | 100.00% | 7,015,455 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.67% | 0.20% | 821,518 | 265,890 | 47.85% | 21,351,253 | Jun 30, 2024 |
| ABRDN PLC | 0.20% | 0.01% | 248,670 | 248,670 | 100.00% | 6,462,933 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.19% | 0.01% | 231,539 | 231,539 | 100.00% | 6,016,044 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.18% | 0.03% | 220,371 | 220,371 | 100.00% | 5,727,442 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.02% | 0.01% | 1,263,442 | 213,903 | 20.38% | 32,836,857 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.43% | 0.01% | 529,251 | 202,280 | 61.86% | 13,755,233 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.38% | 0.01% | 2,937,948 | 183,314 | 6.65% | 76,372,209 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.15% | 0.01% | 188,313 | 155,011 | 465.47% | 4,894,255 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 2.59% | 2.11% | 3,189,389 | 152,721 | 5.03% | 82,892,220 | Jun 30, 2024 |
| EVENTIDE ASSET MANAGEMENT, LLC | 0.38% | 0.21% | 463,894 | 150,605 | 48.07% | 12,056,605 | Jun 30, 2024 |
As of Jun 30 2024, Arrowhead Pharmaceuticals's largest institutional buyer is NORGES BANK. The company purchased 1.59M stocks of ARWR, valued at $41.20M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | - | - | - | -739,651 | -100.00% | - | Jun 30, 2024 |
| STATE STREET CORP | 4.74% | 0.01% | 5,837,762 | -722,941 | -11.02% | 151,723,434,000 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 0.60% | 0.02% | 743,684 | -482,303 | -39.34% | 19,328,347 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 0.00% | 0.00% | 3,708 | -324,074 | -98.87% | 95,259 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 1.88% | 0.00% | 2,315,705 | -322,358 | -12.22% | 60,185,173 | Jun 30, 2024 |
| ROKOS CAPITAL MANAGEMENT LLP | 0.76% | 0.15% | 939,984 | -289,164 | -23.53% | 24,410,662 | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | 0.60% | 0.01% | 738,200 | -259,097 | -25.98% | 19,185,818 | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 0.07% | 0.01% | 88,150 | -256,317 | -74.41% | 2,291,019 | Jun 30, 2024 |
| OCTAGON CAPITAL ADVISORS LP | - | - | - | -250,000 | -100.00% | - | Jun 30, 2024 |
| CAPITAL INTERNATIONAL INVESTORS | 0.21% | 0.00% | 255,871 | -223,235 | -46.59% | 6,650,087 | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -220,217 | -100.00% | - | Jun 30, 2024 |
| NATIXIS | - | - | - | -204,000 | -100.00% | - | Jun 30, 2024 |
| RETIREMENT SYSTEMS OF ALABAMA | 0.12% | 0.02% | 153,292 | -195,492 | -56.05% | 3,984,059 | Jun 30, 2024 |
| VANGUARD GROUP INC | 9.91% | 0.01% | 12,214,101 | -189,949 | -1.53% | 317,444,486 | Jun 30, 2024 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | - | - | - | -128,083 | -100.00% | - | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.12% | 0.01% | 149,599 | -124,560 | -45.43% | 3,888,078 | Jun 30, 2024 |
| BARCLAYS PLC | 0.09% | 0.00% | 109,054 | -114,094 | -51.13% | 2,835,000 | Jun 30, 2024 |
| UBS GROUP AG | 0.28% | 0.00% | 348,304 | -102,617 | -22.76% | 9,052,421 | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 0.03% | 0.00% | 39,404 | -76,687 | -66.06% | 1,024,110 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 0.04% | 0.15% | 50,000 | -70,000 | -58.33% | 1,299,500 | Jun 30, 2024 |
As of Jun 30 2024, Arrowhead Pharmaceuticals's biggest institutional seller is ORBIMED ADVISORS LLC. The company sold -0.74M shares of ARWR, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NORGES BANK | 1.29% | 0.01% | 1,585,320 | 1,585,320 | 100.00% | 41,202,467 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.31% | 0.02% | 383,826 | 383,826 | 100.00% | 9,975,638 | Jun 30, 2024 |
| HOUND PARTNERS, LLC | 0.22% | 1.41% | 269,929 | 269,929 | 100.00% | 7,015,455 | Jun 30, 2024 |
| ABRDN PLC | 0.20% | 0.01% | 248,670 | 248,670 | 100.00% | 6,462,933 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.19% | 0.01% | 231,539 | 231,539 | 100.00% | 6,016,044 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.18% | 0.03% | 220,371 | 220,371 | 100.00% | 5,727,442 | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 0.09% | 3.64% | 111,133 | 111,133 | 100.00% | 2,888,347 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 0.08% | 0.00% | 100,000 | 100,000 | 100.00% | 2,599,000 | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | 0.08% | 0.04% | 97,470 | 97,470 | 100.00% | 2,533,245 | Jun 30, 2024 |
| READYSTATE ASSET MANAGEMENT LP | 0.05% | 0.05% | 56,492 | 56,492 | 100.00% | 1,468,227 | Jun 30, 2024 |
| CENTERBOOK PARTNERS LP | 0.04% | 0.08% | 50,766 | 50,766 | 100.00% | 1,319,408 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.03% | 0.01% | 42,351 | 42,351 | 100.00% | 1,100,702 | Jun 30, 2024 |
| FUND 1 INVESTMENTS, LLC | 0.03% | 0.11% | 39,400 | 39,400 | 100.00% | 1,024,006 | Jun 30, 2024 |
| CAPITAL FUND MANAGEMENT S.A. | 0.03% | 0.00% | 37,130 | 37,130 | 100.00% | 965,008 | Jun 30, 2024 |
| EISLER CAPITAL (US) LLC | 0.03% | 0.01% | 32,054 | 32,054 | 100.00% | 833,083 | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | 0.02% | 0.01% | 24,489 | 24,489 | 100.00% | 636,470 | Jun 30, 2024 |
| TOROSO INVESTMENTS, LLC | 0.02% | 0.01% | 22,311 | 22,311 | 100.00% | 579,862 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 0.02% | 0.01% | 19,461 | 19,461 | 100.00% | 505,791 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 0.01% | 0.00% | 14,600 | 14,600 | 100.00% | 379,454 | Jun 30, 2024 |
| FISHER ASSET MANAGEMENT, LLC | 0.01% | 0.00% | 11,744 | 11,744 | 100.00% | 305,226 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.01% | 0.00% | 11,300 | 11,300 | 100.00% | 293,687 | Jun 30, 2024 |
| AMUNDI | 0.01% | 0.00% | 6,791 | 6,791 | 100.00% | 170,250 | Jun 30, 2024 |
| NVERSES CAPITAL, LLC | 0.00% | 0.06% | 3,700 | 3,700 | 100.00% | 96,163 | Jun 30, 2024 |
| PICTON MAHONEY ASSET MANAGEMENT | 0.00% | 0.00% | 237 | 237 | 100.00% | 6,000 | Jun 30, 2024 |
| CLEARSTEAD ADVISORS, LLC | 0.00% | 0.00% | 144 | 144 | 100.00% | 3,743 | Jun 30, 2024 |
| RONALD BLUE TRUST, INC. | - | - | 44 | 44 | 100.00% | 1,258 | Jun 30, 2024 |
| HUNTINGTON NATIONAL BANK | - | - | 12 | 12 | 100.00% | 312 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | - | 0.00% | 11 | 11 | 100.00% | 286 | Jun 30, 2024 |
| MV CAPITAL MANAGEMENT, INC. | - | - | 9 | 9 | 100.00% | 234 | Jun 30, 2024 |
Arrowhead Pharmaceuticals's largest new institutional shareholder by number of shares is NORGES BANK, purchased 1.59M shares, valued at $41.20M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | - | - | - | -739,651 | -100.00% | - | Jun 30, 2024 |
| OCTAGON CAPITAL ADVISORS LP | - | - | - | -250,000 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -220,217 | -100.00% | - | Jun 30, 2024 |
| NATIXIS | - | - | - | -204,000 | -100.00% | - | Jun 30, 2024 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | - | - | - | -128,083 | -100.00% | - | Jun 30, 2024 |
| TUDOR INVESTMENT CORP ET AL | - | - | - | -69,330 | -100.00% | - | Jun 30, 2024 |
| EXOME ASSET MANAGEMENT LLC | - | - | - | -55,700 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -53,000 | -100.00% | - | Jun 30, 2024 |
| EVOLUTIONARY TREE CAPITAL MANAGEMENT, LLC | - | - | - | -44,896 | -100.00% | - | Jun 30, 2024 |
| GLOBAL ASSETS ADVISORY, LLC | - | - | - | -40,242 | -100.00% | - | Jun 30, 2024 |
| CAMPBELL & CO INVESTMENT ADVISER LLC | - | - | - | -37,816 | -100.00% | - | Jun 30, 2024 |
| HARBOR CAPITAL ADVISORS, INC. | - | - | - | -26,832 | -100.00% | - | Jun 30, 2024 |
| BAYESIAN CAPITAL MANAGEMENT, LP | - | - | - | -25,303 | -100.00% | - | Jun 30, 2024 |
| MARINER, LLC | - | - | - | -22,199 | -100.00% | - | Jun 30, 2024 |
| PANAGORA ASSET MANAGEMENT INC | - | - | - | -18,542 | -100.00% | - | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | - | - | - | -15,000 | -100.00% | - | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | - | - | - | -13,000 | -100.00% | - | Jun 30, 2024 |
| MAN GROUP PLC | - | - | - | -12,117 | -100.00% | - | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -10,999 | -100.00% | - | Jun 30, 2024 |
| HSBC HOLDINGS PLC | - | - | - | -9,521 | -100.00% | - | Jun 30, 2024 |
| OXFORD ASSET MANAGEMENT LLP | - | - | - | -9,520 | -100.00% | - | Jun 30, 2024 |
| WOLVERINE TRADING, LLC | - | - | - | -9,441 | -100.00% | - | Jun 30, 2024 |
| PICTET & CIE (EUROPE) SA | - | - | - | -8,125 | -100.00% | - | Jun 30, 2024 |
| GRAHAM CAPITAL MANAGEMENT, L.P. | - | - | - | -7,983 | -100.00% | - | Jun 30, 2024 |
| MACKENZIE FINANCIAL CORP | - | - | - | -7,299 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -6,101 | -100.00% | - | Jun 30, 2024 |
| HEADLANDS TECHNOLOGIES LLC | - | - | - | -2,417 | -100.00% | - | Jun 30, 2024 |
| FRED ALGER MANAGEMENT, LLC | - | - | - | -1,543 | -100.00% | - | Jun 30, 2024 |
| QUEST PARTNERS LLC | - | - | - | -970 | -100.00% | - | Jun 30, 2024 |
| CHILTON CAPITAL MANAGEMENT LLC | - | - | - | -600 | -100.00% | - | Jun 30, 2024 |
| TORNO CAPITAL, LLC | - | - | - | -600 | -100.00% | - | Jun 30, 2024 |
| NEW COVENANT TRUST COMPANY, N.A. | - | - | - | -269 | -100.00% | - | Jun 30, 2024 |
| SYSTM WEALTH SOLUTIONS LLC | - | - | - | -42 | -100.00% | - | Jun 30, 2024 |
| BELL INVESTMENT ADVISORS, INC | - | - | - | -19 | -100.00% | - | Jun 30, 2024 |
| RIGGS ASSET MANAGMENT CO. INC. | - | - | - | -14 | -100.00% | - | Jun 30, 2024 |
| ADVISORNET FINANCIAL, INC | - | - | - | -7 | -100.00% | - | Jun 30, 2024 |
| FINANCIAL GRAVITY ASSET MANAGEMENT, INC. | - | - | - | -4 | -100.00% | - | Jun 30, 2024 |
Arrowhead Pharmaceuticals's largest sold out institutional shareholder by shares sold is ORBIMED ADVISORS LLC, sold -0.74M shares, valued at -, as of undefined.
Arrowhead Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Alger ETF Trust | 2.09% | 14,843 | - | - | Dec 31, 2023 |
| AGF Investments Trust | 1.75% | -33,153 | 5,829 | -14.95% | Mar 31, 2024 |
| Fiera Capital Series Trust | 1.42% | 28,228 | - | - | Jun 30, 2023 |
| Manager Directed Portfolios | 0.98% | 161,002 | - | - | Jan 31, 2024 |
| Tema ETF Trust | 0.61% | 27,264 | 18,240 | 202.13% | Feb 29, 2024 |
| AB DISCOVERY GROWTH FUND, INC. | 0.30% | 454,157 | - | - | Jan 31, 2024 |
| SPDR S&P MIDCAP 400 ETF TRUST | 0.26% | 1,012,978 | 143,970 | 16.57% | Mar 28, 2024 |
| BNY MELLON INDEX FUNDS, INC. | 0.19% | 252,467 | - | - | Apr 30, 2022 |
| HARTFORD HLS SERIES FUND II INC | 0.18% | 43,269 | - | - | Dec 31, 2023 |
| BNY MELLON MIDCAP INDEX FUND, INC. | 0.18% | 75,669 | 6,028 | 8.66% | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.14% | 72,044 | - | - | Mar 31, 2024 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 0.12% | 452,300 | 452,300 | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND III | 0.08% | 663,856 | 150,556 | 29.33% | Mar 31, 2024 |
| EntrepreneurShares Series Trust | 0.08% | 20,670 | - | - | Dec 31, 2023 |
| TEKLA HEALTHCARE INVESTORS | 0.08% | 65,953 | - | - | Mar 31, 2024 |
| Vanguard Montgomery Funds | 0.07% | 17,680 | - | - | Mar 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.07% | 34,469 | - | - | Mar 31, 2024 |
| WANGER ADVISORS TRUST | 0.07% | 39,629 | - | - | Mar 31, 2024 |
| SYNTAX ETF TRUST | 0.07% | 2,159 | -845 | -28.13% | Mar 31, 2024 |
| COLUMBIA ACORN TRUST | 0.07% | 214,574 | - | - | Mar 31, 2024 |
| T. Rowe Price Small-Cap Value Fund, Inc. | 0.06% | 464,100 | 464,100 | - | Mar 31, 2024 |
| VANGUARD ADMIRAL FUNDS | 0.06% | 250,614 | 27,214 | 12.18% | Feb 29, 2024 |
| AIM INTERNATIONAL MUTUAL FUNDS (INVESCO INTERNATIONAL MUTUAL FUNDS) | 0.05% | 1,803,700 | - | - | Jan 31, 2024 |
| Federated Hermes Index Trust | 0.05% | 10,722 | 2,266 | 26.80% | Jan 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.05% | 399,890 | 104,404 | 35.33% | Jan 31, 2024 |
| Voya EQUITY TRUST | 0.05% | 68,820 | 64,522 | 1501.21% | Feb 29, 2024 |
| Humankind Benefit Corp | 0.05% | 1,039 | 13 | 1.27% | Dec 31, 2023 |
| Voya VARIABLE PRODUCTS TRUST | 0.04% | 16,028 | -767 | -4.57% | Mar 31, 2024 |
| ALGER FUNDS | 0.04% | 37,093 | -1,169 | -3.06% | Jan 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.04% | 408,211 | 103,611 | 34.02% | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.03% | 205,028 | 20,785 | 11.28% | Mar 31, 2024 |
| BlackRock Health Sciences Trust II | 0.03% | 81,025 | 259 | 0.32% | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.03% | 17,231 | 1,716 | 11.06% | Mar 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.03% | 803,645 | 557,790 | 226.88% | Feb 29, 2024 |
| Calvert Responsible Index Series, Inc. | 0.03% | 45,509 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.02% | 10,327,681 | -119,024 | -1.14% | Mar 31, 2024 |
| AB CAP FUND, INC. | 0.02% | 795,223 | - | - | Jan 31, 2024 |
| Northern Lights Variable Trust | 0.02% | 21,964 | - | - | Mar 31, 2024 |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 0.02% | 147,561 | - | - | Mar 31, 2024 |
| VANGUARD EXPLORER FUND | 0.02% | 241,607 | -34,816 | -12.60% | Jan 31, 2024 |
| T. Rowe Price Equity Funds, Inc. | 0.02% | 212,393 | 212,393 | - | Mar 31, 2024 |
| BUFFALO FUNDS | 0.02% | 126,510 | - | - | Mar 31, 2024 |
| FIDELITY SECURITIES FUND | 0.02% | 1,682,804 | 903,721 | 116.00% | Jan 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.02% | 66,195 | - | - | Jan 31, 2024 |
| PRUDENTIAL JENNISON BLEND FUND, INC. | 0.02% | 9,665 | - | - | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.01% | 38,867 | 4,640 | 13.56% | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENT TRUST | 0.01% | 43,058 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.01% | 272,100 | 154,500 | 131.38% | Mar 31, 2024 |
| TrimTabs ETF Trust | 0.01% | 8,359 | - | - | Jan 31, 2024 |
| AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC. | 0.01% | 28,011 | - | - | Mar 31, 2024 |
| JNL VARIABLE FUND LLC | 0.01% | 63,880 | - | - | Mar 31, 2020 |
| FIDELITY SELECT PORTFOLIOS | 0.01% | 713,170 | -141,462 | -16.55% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.01% | 47,036 | 12,915 | 37.85% | Dec 31, 2023 |
| BNY MELLON INVESTMENT PORTFOLIOS | 0.01% | 5,670 | - | - | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 2,078 | - | - | Mar 31, 2024 |
| NEUBERGER BERMAN EQUITY FUNDS | 0.01% | 85,046 | - | - | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.01% | 346,552 | 32,369 | 10.30% | Jan 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 25,946 | 403 | 1.58% | Feb 29, 2024 |
| MUTUAL OF AMERICA INSTITUTIONAL FUNDS INC | 0.01% | 4,277 | 2,258 | 111.84% | Sep 30, 2020 |
| Bernstein Fund Inc | 0.01% | 64,492 | - | - | Mar 31, 2024 |
| HUSSMAN INVESTMENT TRUST | 0.01% | 25,500 | - | - | Dec 31, 2023 |
| RYDEX VARIABLE TRUST | 0.01% | 8,300 | 4,470 | 116.71% | Dec 31, 2023 |
| EXCHANGE TRADED CONCEPTS TRUST | 0.01% | 41,046 | -7,499 | -15.45% | Jan 31, 2024 |
| SMALLCAP WORLD FUND INC | 0.01% | 479,106 | -798,454 | -62.50% | Mar 31, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.01% | 60,626 | - | - | Mar 28, 2024 |
| FIDELITY CONTRAFUND | 0.01% | 435,104 | - | - | Mar 31, 2024 |
| John Hancock Exchange-Traded Fund Trust | 0.01% | 36,755 | - | - | Jan 31, 2024 |
| ALPS ETF Trust | 0.01% | 71,805 | - | - | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.01% | 1,154,089 | 177,147 | 18.13% | Feb 29, 2024 |
| UBS FUNDS | 0.01% | 25,011 | - | - | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 2,448 | -200 | -7.55% | Apr 30, 2021 |
| Mutual of America Variable Insurance Portfolios, Inc. | 0.00% | 3,264 | -93 | -2.77% | Sep 30, 2023 |
| Nushares ETF Trust | 0.00% | 32,033 | -25,722 | -44.54% | Jan 31, 2024 |
| VANGUARD TAX-MANAGED FUNDS | 0.00% | 870,998 | - | - | Mar 31, 2024 |
| Federated Hermes MDT Series | 0.00% | 9,486 | - | - | Jan 31, 2024 |
| Natixis Funds Trust IV | 0.00% | 1,181 | - | - | Jan 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 310,858 | 66,784 | 27.36% | Jan 31, 2024 |
| ROYCE FUND | 0.00% | 22,000 | - | - | Mar 31, 2024 |
| IndexIQ ETF Trust | 0.00% | 7,361 | - | - | Jan 31, 2024 |
| Goldman Sachs ETF Trust II | 0.00% | 3,363 | - | - | Feb 29, 2024 |
| FORUM FUNDS | 0.00% | 6,950 | - | - | Jan 31, 2024 |
| CARILLON SERIES TRUST | 0.00% | 159,623 | - | - | Mar 31, 2024 |
| Advisors Preferred Trust | 0.00% | 19,194 | - | - | Mar 31, 2024 |
| SHELTON FUNDS | 0.00% | 4,623 | -317 | -6.42% | Feb 29, 2024 |
| BARON SELECT FUNDS | 0.00% | 28,000 | - | - | Mar 31, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 17,815 | - | - | Aug 31, 2023 |
| AB VARIABLE PRODUCTS SERIES FUND, INC. | 0.00% | 11,139 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 73,872 | 7,711 | 11.65% | Mar 31, 2024 |
| STEWARD FUNDS, INC. | 0.00% | 5,688 | 65 | 1.16% | Jan 31, 2024 |
| SSGA FUNDS | 0.00% | 1,019 | - | - | Feb 29, 2024 |
| PFM Multi-Manager Series Trust | 0.00% | 1,900 | - | - | Dec 31, 2023 |
| Direxion Shares ETF Trust | 0.00% | 350,528 | 116,824 | 49.99% | Jan 31, 2024 |
| ETFis Series Trust I | 0.00% | 2,875 | 76 | 2.72% | Jan 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 37,876 | 4,575 | 13.74% | Mar 31, 2024 |
| Exchange Listed Funds Trust | 0.00% | 2,192 | - | - | Feb 29, 2024 |
| JANUS INVESTMENT FUND | 0.00% | 553,718 | - | - | Dec 31, 2023 |
| VANGUARD WORLD FUND | 0.00% | 441,308 | 76,822 | 21.08% | Feb 29, 2024 |
| MUTUAL OF AMERICA INVESTMENT CORP | 0.00% | 71,950 | 8,673 | 13.71% | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 48,464 | -5,854 | -10.78% | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 18,165 | 4,210 | 30.17% | Mar 31, 2024 |
Arrowhead Pharmaceuticals's largest mutual fund holder by % of total assets is "Alger ETF Trust", owning 14.84K shares, compromising 2.09% of its total assets.
Arrowhead Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 276 | -3.16% |
| 31 Mar, 24 | 285 | 1.06% |
| 31 Dec, 23 | 282 | 9.73% |
| 30 Sep, 23 | 257 | -9.51% |
| 30 Jun, 23 | 284 | 6.37% |
| 31 Mar, 23 | 267 | -8.56% |
| 31 Dec, 22 | 292 | 3.18% |
| 30 Sep, 22 | 283 | 0.35% |
| 30 Jun, 22 | 282 | -9.90% |
| 31 Mar, 22 | 313 | -3.69% |
| 31 Dec, 21 | 325 | 5.52% |
| 30 Sep, 21 | 308 | -5.81% |
| 30 Jun, 21 | 327 | 8.64% |
| 31 Mar, 21 | 301 | -9.06% |
| 31 Dec, 20 | 331 | 18.21% |
| 30 Sep, 20 | 280 | 4.48% |
| 30 Jun, 20 | 268 | 2.29% |
| 31 Mar, 20 | 262 | -18.13% |
| 31 Dec, 19 | 320 | 31.69% |
| 30 Sep, 19 | 243 | 6.11% |
| 30 Jun, 19 | 229 | 21.81% |
| 31 Mar, 19 | 188 | 8.67% |
| 31 Dec, 18 | 173 | 15.33% |
| 30 Sep, 18 | 150 | 17.19% |
| 30 Jun, 18 | 128 | 31.96% |
| 31 Mar, 18 | 97 | 14.12% |
| 31 Dec, 17 | 85 | 34.92% |
| 30 Sep, 17 | 63 | 1.61% |
| 30 Jun, 17 | 62 | -29.55% |
| 31 Mar, 17 | 88 | -5.38% |
| 31 Dec, 16 | 93 | -14.68% |
| 30 Sep, 16 | 109 | 11.22% |
| 30 Jun, 16 | 98 | 1125.00% |
| 31 Mar, 16 | 8 | 700.00% |
| 31 Dec, 15 | 1 | - |
| 30 Sep, 15 | 1 | - |
| 30 Jun, 15 | 1 | - |
| 31 Mar, 15 | 1 | - |
| 31 Dec, 14 | 1 | - |
As of 30 Jun 24, 276 institutions are holding Arrowhead Pharmaceuticals's shares, representing a decrease of -3.16% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 97,691,954 | 2.85% |
| 31 Mar, 24 | 94,985,134 | 22.73% |
| 31 Dec, 23 | 77,394,796 | 5.41% |
| 30 Sep, 23 | 73,420,771 | 1.59% |
| 30 Jun, 23 | 72,271,971 | -0.95% |
| 31 Mar, 23 | 72,967,375 | -0.32% |
| 31 Dec, 22 | 73,204,931 | 3.10% |
| 30 Sep, 22 | 71,004,896 | -1.64% |
| 30 Jun, 22 | 72,186,494 | 4.33% |
| 31 Mar, 22 | 69,187,421 | 1.50% |
| 31 Dec, 21 | 68,162,804 | 2.28% |
| 30 Sep, 21 | 66,645,109 | -0.37% |
| 30 Jun, 21 | 66,891,923 | -2.35% |
| 31 Mar, 21 | 68,499,131 | -1.35% |
| 31 Dec, 20 | 69,438,424 | 1.76% |
| 30 Sep, 20 | 68,240,246 | -0.65% |
| 30 Jun, 20 | 68,685,065 | 3.65% |
| 31 Mar, 20 | 66,267,106 | 2.03% |
| 31 Dec, 19 | 64,946,848 | -1.24% |
| 30 Sep, 19 | 65,761,951 | -3.72% |
| 30 Jun, 19 | 68,299,360 | 15.46% |
| 31 Mar, 19 | 59,153,641 | 0.87% |
| 31 Dec, 18 | 58,642,226 | 4.75% |
| 30 Sep, 18 | 55,980,786 | 8.10% |
| 30 Jun, 18 | 51,784,712 | 27.21% |
| 31 Mar, 18 | 40,708,573 | 74.27% |
| 31 Dec, 17 | 23,359,408 | 55.69% |
| 30 Sep, 17 | 15,003,595 | -2.62% |
| 30 Jun, 17 | 15,406,848 | -36.67% |
| 31 Mar, 17 | 24,328,155 | -4.51% |
| 31 Dec, 16 | 25,475,966 | -15.59% |
| 30 Sep, 16 | 30,180,649 | 46.48% |
| 30 Jun, 16 | 20,604,092 | 867.08% |
| 31 Mar, 16 | 2,130,549 | 426009.80% |
| 31 Dec, 15 | 500 | - |
| 30 Sep, 15 | 500 | - |
| 30 Jun, 15 | 500 | - |
| 31 Mar, 15 | 500 | - |
| 31 Dec, 14 | 500 | - |
Arrowhead Pharmaceuticals (ARWR) has 97.69M shares outstanding as of 30 Jun 24, up 2.85% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 79.24% | 1.33% |
| 31 Mar, 24 | 77.05% | 1.48% |
| 31 Dec, 23 | 72.05% | 1.54% |
| 30 Sep, 23 | 68.42% | 1.50% |
| 30 Jun, 23 | 67.54% | 1.45% |
| 31 Mar, 23 | 68.35% | 1.43% |
| 31 Dec, 22 | 69.04% | 1.53% |
| 30 Sep, 22 | 67.14% | 1.44% |
| 30 Jun, 22 | 68.26% | 1.59% |
| 31 Mar, 22 | 65.55% | 1.54% |
| 31 Dec, 21 | 65.21% | 1.60% |
| 30 Sep, 21 | 63.91% | 1.52% |
| 30 Jun, 21 | 64.83% | 1.47% |
| 31 Mar, 21 | 66.41% | 1.45% |
| 31 Dec, 20 | 67.58% | 1.52% |
| 30 Sep, 20 | 66.68% | 1.47% |
| 30 Jun, 20 | 67.44% | 1.51% |
| 31 Mar, 20 | 66.81% | 1.49% |
| 31 Dec, 19 | 66.89% | 1.41% |
| 30 Sep, 19 | 68.97% | 1.33% |
| 30 Jun, 19 | 71.94% | 1.82% |
| 31 Mar, 19 | 62.83% | 1.52% |
| 31 Dec, 18 | 64.38% | 1.70% |
| 30 Sep, 18 | 61.46% | 1.72% |
| 30 Jun, 18 | 59.73% | 2.46% |
| 31 Mar, 18 | 49.23% | 4.85% |
| 31 Dec, 17 | 31.86% | 7.57% |
| 30 Sep, 17 | 20.51% | 4.83% |
| 30 Jun, 17 | 20.61% | 1.94% |
| 31 Mar, 17 | 32.60% | 2.54% |
| 31 Dec, 16 | 35.83% | 1.46% |
| 30 Sep, 16 | 49.49% | 4.19% |
| 30 Jun, 16 | 34.36% | 267.74% |
| 31 Mar, 16 | 3.58% | 533307025.00% |
| 31 Dec, 15 | 0.00% | 124987.50% |
| 30 Sep, 15 | 0.00% | 123912.50% |
| 30 Jun, 15 | 0.00% | 104888.89% |
| 31 Mar, 15 | 0.00% | 109066.67% |
| 31 Dec, 14 | 0.00% | - |
As of 30 Jun 24, Arrowhead Pharmaceuticals is held by 79.24% institutional shareholders, representing a 1.33% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 131 | -10.27% |
| 31 Mar, 24 | 146 | 18.70% |
| 31 Dec, 23 | 123 | 8.85% |
| 30 Sep, 23 | 113 | -5.04% |
| 30 Jun, 23 | 119 | 0.85% |
| 31 Mar, 23 | 118 | -15.71% |
| 31 Dec, 22 | 140 | 13.82% |
| 30 Sep, 22 | 123 | -5.38% |
| 30 Jun, 22 | 130 | -15.03% |
| 31 Mar, 22 | 153 | -0.65% |
| 31 Dec, 21 | 154 | 6.94% |
| 30 Sep, 21 | 144 | -5.88% |
| 30 Jun, 21 | 153 | 28.57% |
| 31 Mar, 21 | 119 | -26.09% |
| 31 Dec, 20 | 161 | 31.97% |
| 30 Sep, 20 | 122 | -12.86% |
| 30 Jun, 20 | 140 | 17.65% |
| 31 Mar, 20 | 119 | -31.61% |
| 31 Dec, 19 | 174 | 37.01% |
| 30 Sep, 19 | 127 | -9.29% |
| 30 Jun, 19 | 140 | 53.85% |
| 31 Mar, 19 | 91 | -8.08% |
| 31 Dec, 18 | 99 | 12.50% |
| 30 Sep, 18 | 88 | 10.00% |
| 30 Jun, 18 | 80 | 35.59% |
| 31 Mar, 18 | 59 | 20.41% |
| 31 Dec, 17 | 49 | 81.48% |
| 30 Sep, 17 | 27 | 3.85% |
| 30 Jun, 17 | 26 | -23.53% |
| 31 Mar, 17 | 34 | -20.93% |
| 31 Dec, 16 | 43 | -31.75% |
| 30 Sep, 16 | 63 | -23.17% |
| 30 Jun, 16 | 82 | 1071.43% |
| 31 Mar, 16 | 7 | - |
| 31 Dec, 15 | - | - |
| 30 Sep, 15 | - | - |
| 30 Jun, 15 | - | - |
| 31 Mar, 15 | - | -100.00% |
| 31 Dec, 14 | 1 | - |
131 institutional shareholders have increased their position in ARWR stock as of 30 Jun 24 compared to 146 in the previous quarter (a -10.27% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 81 | 8.00% |
| 31 Mar, 24 | 75 | -20.21% |
| 31 Dec, 23 | 94 | - |
| 30 Sep, 23 | 94 | -14.55% |
| 30 Jun, 23 | 110 | 17.02% |
| 31 Mar, 23 | 94 | -5.05% |
| 31 Dec, 22 | 99 | 1.02% |
| 30 Sep, 22 | 98 | - |
| 30 Jun, 22 | 98 | -2.97% |
| 31 Mar, 22 | 101 | -9.82% |
| 31 Dec, 21 | 112 | 10.89% |
| 30 Sep, 21 | 101 | -6.48% |
| 30 Jun, 21 | 108 | -9.24% |
| 31 Mar, 21 | 119 | 5.31% |
| 31 Dec, 20 | 113 | 17.71% |
| 30 Sep, 20 | 96 | 31.51% |
| 30 Jun, 20 | 73 | -19.78% |
| 31 Mar, 20 | 91 | - |
| 31 Dec, 19 | 91 | 33.82% |
| 30 Sep, 19 | 68 | 30.77% |
| 30 Jun, 19 | 52 | -11.86% |
| 31 Mar, 19 | 59 | 40.48% |
| 31 Dec, 18 | 42 | 68.00% |
| 30 Sep, 18 | 25 | - |
| 30 Jun, 18 | 25 | 56.25% |
| 31 Mar, 18 | 16 | - |
| 31 Dec, 17 | 16 | 6.67% |
| 30 Sep, 17 | 15 | -11.76% |
| 30 Jun, 17 | 17 | -29.17% |
| 31 Mar, 17 | 24 | - |
| 31 Dec, 16 | 24 | 41.18% |
| 30 Sep, 16 | 17 | 750.00% |
| 30 Jun, 16 | 2 | - |
| 31 Mar, 16 | - | - |
| 31 Dec, 15 | - | - |
| 30 Sep, 15 | - | - |
| 30 Jun, 15 | - | - |
| 31 Mar, 15 | - | - |
| 31 Dec, 14 | - | - |
81 institutional shareholders have reduced their position in ARWR stock as of 30 Jun 24 compared to 75 in the previous quarter (a 8.00% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 276 | -3.16% | 97,691,954 | 2.85% | 79.24% | 1.33% | 131 | -10.27% | 81 | 8.00% |
| 31 Mar, 24 | 285 | 1.06% | 94,985,134 | 22.73% | 77.05% | 1.48% | 146 | 18.70% | 75 | -20.21% |
| 31 Dec, 23 | 282 | 9.73% | 77,394,796 | 5.41% | 72.05% | 1.54% | 123 | 8.85% | 94 | - |
| 30 Sep, 23 | 257 | -9.51% | 73,420,771 | 1.59% | 68.42% | 1.50% | 113 | -5.04% | 94 | -14.55% |
| 30 Jun, 23 | 284 | 6.37% | 72,271,971 | -0.95% | 67.54% | 1.45% | 119 | 0.85% | 110 | 17.02% |
| 31 Mar, 23 | 267 | -8.56% | 72,967,375 | -0.32% | 68.35% | 1.43% | 118 | -15.71% | 94 | -5.05% |
| 31 Dec, 22 | 292 | 3.18% | 73,204,931 | 3.10% | 69.04% | 1.53% | 140 | 13.82% | 99 | 1.02% |
| 30 Sep, 22 | 283 | 0.35% | 71,004,896 | -1.64% | 67.14% | 1.44% | 123 | -5.38% | 98 | - |
| 30 Jun, 22 | 282 | -9.90% | 72,186,494 | 4.33% | 68.26% | 1.59% | 130 | -15.03% | 98 | -2.97% |
| 31 Mar, 22 | 313 | -3.69% | 69,187,421 | 1.50% | 65.55% | 1.54% | 153 | -0.65% | 101 | -9.82% |
| 31 Dec, 21 | 325 | 5.52% | 68,162,804 | 2.28% | 65.21% | 1.60% | 154 | 6.94% | 112 | 10.89% |
| 30 Sep, 21 | 308 | -5.81% | 66,645,109 | -0.37% | 63.91% | 1.52% | 144 | -5.88% | 101 | -6.48% |
| 30 Jun, 21 | 327 | 8.64% | 66,891,923 | -2.35% | 64.83% | 1.47% | 153 | 28.57% | 108 | -9.24% |
| 31 Mar, 21 | 301 | -9.06% | 68,499,131 | -1.35% | 66.41% | 1.45% | 119 | -26.09% | 119 | 5.31% |
| 31 Dec, 20 | 331 | 18.21% | 69,438,424 | 1.76% | 67.58% | 1.52% | 161 | 31.97% | 113 | 17.71% |
| 30 Sep, 20 | 280 | 4.48% | 68,240,246 | -0.65% | 66.68% | 1.47% | 122 | -12.86% | 96 | 31.51% |
| 30 Jun, 20 | 268 | 2.29% | 68,685,065 | 3.65% | 67.44% | 1.51% | 140 | 17.65% | 73 | -19.78% |
| 31 Mar, 20 | 262 | -18.13% | 66,267,106 | 2.03% | 66.81% | 1.49% | 119 | -31.61% | 91 | - |
| 31 Dec, 19 | 320 | 31.69% | 64,946,848 | -1.24% | 66.89% | 1.41% | 174 | 37.01% | 91 | 33.82% |
| 30 Sep, 19 | 243 | 6.11% | 65,761,951 | -3.72% | 68.97% | 1.33% | 127 | -9.29% | 68 | 30.77% |
| 30 Jun, 19 | 229 | 21.81% | 68,299,360 | 15.46% | 71.94% | 1.82% | 140 | 53.85% | 52 | -11.86% |
| 31 Mar, 19 | 188 | 8.67% | 59,153,641 | 0.87% | 62.83% | 1.52% | 91 | -8.08% | 59 | 40.48% |
| 31 Dec, 18 | 173 | 15.33% | 58,642,226 | 4.75% | 64.38% | 1.70% | 99 | 12.50% | 42 | 68.00% |
| 30 Sep, 18 | 150 | 17.19% | 55,980,786 | 8.10% | 61.46% | 1.72% | 88 | 10.00% | 25 | - |
| 30 Jun, 18 | 128 | 31.96% | 51,784,712 | 27.21% | 59.73% | 2.46% | 80 | 35.59% | 25 | 56.25% |
| 31 Mar, 18 | 97 | 14.12% | 40,708,573 | 74.27% | 49.23% | 4.85% | 59 | 20.41% | 16 | - |
| 31 Dec, 17 | 85 | 34.92% | 23,359,408 | 55.69% | 31.86% | 7.57% | 49 | 81.48% | 16 | 6.67% |
| 30 Sep, 17 | 63 | 1.61% | 15,003,595 | -2.62% | 20.51% | 4.83% | 27 | 3.85% | 15 | -11.76% |
| 30 Jun, 17 | 62 | -29.55% | 15,406,848 | -36.67% | 20.61% | 1.94% | 26 | -23.53% | 17 | -29.17% |
| 31 Mar, 17 | 88 | -5.38% | 24,328,155 | -4.51% | 32.60% | 2.54% | 34 | -20.93% | 24 | - |
| 31 Dec, 16 | 93 | -14.68% | 25,475,966 | -15.59% | 35.83% | 1.46% | 43 | -31.75% | 24 | 41.18% |
| 30 Sep, 16 | 109 | 11.22% | 30,180,649 | 46.48% | 49.49% | 4.19% | 63 | -23.17% | 17 | 750.00% |
| 30 Jun, 16 | 98 | 1125.00% | 20,604,092 | 867.08% | 34.36% | 267.74% | 82 | 1071.43% | 2 | - |
| 31 Mar, 16 | 8 | 700.00% | 2,130,549 | 426009.80% | 3.58% | 533307025.00% | 7 | - | - | - |
| 31 Dec, 15 | 1 | - | 500 | - | 0.00% | 124987.50% | - | - | - | - |
| 30 Sep, 15 | 1 | - | 500 | - | 0.00% | 123912.50% | - | - | - | - |
| 30 Jun, 15 | 1 | - | 500 | - | 0.00% | 104888.89% | - | - | - | - |
| 31 Mar, 15 | 1 | - | 500 | - | 0.00% | 109066.67% | - | -100.00% | - | - |
| 31 Dec, 14 | 1 | - | 500 | - | 0.00% | - | 1 | - | - | - |
Arrowhead Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Arrowhead Pharmaceuticals's stock was made by Oliver Tracie on Jul 03 2024, selling 9,394 shares at $25.28 per share (valued at $237.48K). The last insider buy of ARWR was made by Lu Hongbo on Mar 20 2024, buying 1,000 shares at $27.50 per share (worth $27.50K).
Arrowhead Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 1 | - |
| Q2 2024 | - | 2 | - |
| Q1 2024 | 9 | 39 | 23.08% |
| Q4 2023 | 6 | 4 | 150.00% |
| Q3 2023 | 2 | 4 | 50.00% |
| Q2 2023 | 2 | 8 | 25.00% |
| Q1 2023 | 19 | 24 | 79.17% |
| Q4 2022 | 3 | 4 | 75.00% |
| Q3 2022 | 1 | 5 | 20.00% |
| Q2 2022 | - | 1 | - |
| Q1 2022 | 13 | 40 | 32.50% |
| Q4 2021 | 3 | 15 | 20.00% |
| Q3 2021 | - | 3 | - |
| Q2 2021 | - | 3 | - |
| Q1 2021 | 11 | 28 | 39.29% |
| Q4 2020 | 10 | 40 | 25.00% |
| Q3 2020 | 1 | 3 | 33.33% |
| Q2 2020 | 18 | 39 | 46.15% |
| Q1 2020 | 22 | 22 | 100.00% |
| Q4 2019 | 3 | 28 | 10.71% |
0 total buy trades, and 1 total sell trades (buy/sell ratio of 0.00%) were made by Arrowhead Pharmaceuticals's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 1 | - |
| Q2 2024 | - | 2 | - |
| Q1 2024 | 3 | 37 | 8.11% |
| Q4 2023 | - | 4 | - |
| Q3 2023 | - | 4 | - |
| Q2 2023 | - | 6 | - |
| Q1 2023 | - | 23 | - |
| Q4 2022 | - | 3 | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | 38 | - |
| Q4 2021 | 1 | 12 | 8.33% |
| Q3 2021 | - | 3 | - |
| Q2 2021 | - | 3 | - |
| Q1 2021 | - | 27 | - |
| Q4 2020 | 2 | 19 | 10.53% |
| Q3 2020 | - | 1 | - |
| Q2 2020 | 2 | 22 | 9.09% |
| Q1 2020 | 6 | 15 | 40.00% |
| Q4 2019 | - | 22 | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 1 open market sell trades of Arrowhead Pharmaceuticals's stocks.
Arrowhead Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| IONS | Ionis Pharmaceuticals, Inc. |
| INCY | Incyte Corporation |
| APLS | Apellis Pharmaceuticals, Inc. |
| BPMC | Blueprint Medicines Corporation |
| DAWN | Day One Biopharmaceuticals, Inc. |
| BMRN | BioMarin Pharmaceutical Inc. |
| CTMX | CytomX Therapeutics, Inc. |
| PRQR | ProQR Therapeutics N.V. |
| TERN | Terns Pharmaceuticals, Inc. |
| ANNX | Annexon, Inc. |
| ASMB | Assembly Biosciences, Inc. |
| WVE | Wave Life Sciences Ltd. |
| NLTX | Neurogene Inc. |
| KRTX | Karuna Therapeutics, Inc. |
| AMLX | Amylyx Pharmaceuticals, Inc. |
ARWR Ownership FAQ
Who Owns Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals is owned by institutional shareholders (79.24%), insiders (4.47%), and public (16.29%). The largest institutional shareholder of Arrowhead Pharmaceuticals is BLACKROCK INC. (12.72% of total shares) and the top mutual fund owner is Alger ETF Trust (2.09% of total shares).
Who are the major institutional shareholders of Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals's major institutional shareholders are BLACKROCK INC., VANGUARD GROUP INC, AVORO CAPITAL ADVISORS LLC, FMR LLC, and STATE STREET CORP. The top five shareholders own together 40.10% of the company's share outstanding.
How many Arrowhead Pharmaceuticals shareholders are there?
As of Jun 2024, there are 276 institutional shareholders of Arrowhead Pharmaceuticals.
What percentage of Arrowhead Pharmaceuticals is owned by BLACKROCK INC?
BLACKROCK INC owns 15.68M shares of Arrowhead Pharmaceuticals, representing 12.72% of the company's total shares outstanding, valued at $407.61M (as of Jun 2024).
What percentage of Arrowhead Pharmaceuticals is owned by VANGUARD GROUP INC?
As of Jun 2024, VANGUARD GROUP INC holds 12.21M shares of Arrowhead Pharmaceuticals (ARWR), compromising 9.91% of the company, valued at $317.44M.
What percentage of Arrowhead Pharmaceuticals is owned by AVORO CAPITAL ADVISORS LLC?
AVORO CAPITAL ADVISORS LLC is the third largest holder of Arrowhead Pharmaceuticals. The company owns 8.89M of the company's shares outstanding (worth $231.02M).